Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion (dyspepsia), and stomach (abdominal) pain have been reported
Mounjaro and Weight Loss Mounjaro (tirzepatide) is FDA-approved to lower blood sugar levels in people with type 2 diabetes
According to a survey from Leger Healthcare, 8% of respondents are currently on a prescription GLP-1
The impact of their molecular mechanisms has been evidenced by landmark trials, which have repeatedly demonstrated that certain GLP-1 RAsincluding liraglutide, semaglutide, and dulaglutideare particularly efficacious in reducing MACE, especially in patients with established ASCVD
Frequently Asked Questions + What is Ipamorelin